22.53
-0.52 (-2.26%)
-0.52 (-2.26%)
Upgrade to Real-Time
Regular Market
Low
15.88
High
54.2081
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.52 | -2.26% | 22.53 | 13:47:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.03 | 22.19 | 23.30 | 23.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 22.50 | 22.53 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,157 | 805,317 | $ 22.62 | $ 18,215,580 | - | 15.88 - 54.2081 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:48:22 | 5 | $ 22.53 | USD |
Period:
Draw Mode:
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.44B | 152.85M | 127.68M | $ - | $ - | -1.89 | -12.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 288.68k | 13.60% |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.05 | 24.23 | 21.75 | 23.40 | 1,397,859 | 0.48 | 2.18% |
| 1 Month | 27.61 | 28.00 | 21.67 | 24.89 | 1,784,489 | -5.08 | -18.4% |
| 3 Months | 31.88 | 32.10 | 15.88 | 21.41 | 3,893,614 | -9.35 | -29.33% |
| 6 Months | 46.55 | 53.04 | 15.88 | 26.16 | 2,788,998 | -24.02 | -51.6% |
| 1 Year | 27.8435 | 54.2081 | 15.88 | 29.73 | 2,043,163 | -5.31 | -19.08% |
| 3 Years | 14.00 | 54.2081 | 7.26 | 24.56 | 1,706,840 | 8.53 | 60.93% |
| 5 Years | 8.25 | 54.2081 | 4.45 | 22.39 | 1,230,163 | 14.28 | 173.09% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
